Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017598HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017499HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017500HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017750HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017706HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017631HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10017943HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10018561HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10012324HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10013109HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807